Featured Research

from universities, journals, and other organizations

Study Calls For Action On Heart Risks From Certain Anti-cancer Drugs

Date:
April 28, 2008
Source:
American Chemical Society
Summary:
Heart damage from certain anti-cancer drugs no longer should be regarded as a rare or relatively unimportant complication, scientists have concluded in a new overview of research on the cardiotoxicity of anti-cancer drugs. Their review recommends that drug regulatory agencies, physicians, and toxicologists join in a focused research effort to combat the problem.

Conceptual representation of a constellation of factors that synergize with cardiotoxicity induced by a known cardiotoxic drug and make cardiac events occur at lower than expected cumulative doses of that drug.
Credit: Courtesy of P. Menna, E. Salvatorelli and G. Minotti

Heart damage from certain anti-cancer drugs no longer should be regarded as a rare or relatively unimportant complication, scientists in Italy have concluded in a new overview of research on the cardiotoxicity of anti-cancer drugs. Their review recommends that drug regulatory agencies, physicians, and toxicologists join in a focused research effort to combat the problem.

In the new study, Giorgio Minotti, Pierantonio Menna, and Emanuela Salvatorelli point out that the risk of cardiotoxicity may be higher than previously believed, especially in older patients and those with high blood pressure, coronary artery disease, and other risk factors. Studies of long-term survivors of childhood and adult cancer -- more than 10 million people in the United States alone -- also suggest an increased risk of symptomatic cardiac events.

Their review found that newer, targeted drugs can damage the heart, particularly when combined with old-generation chemotherapeutics. "Toxicologists and regulatory agencies and clinicians should therefore join in collaborative efforts that improve early identification of cardiotoxicity and minimize the risks of cardiac events in patients," the article notes.

The article "Cardiotoxicity of Antitumor Drugs" is scheduled for the May 19 issue of Chemical Research in Toxicology,


Story Source:

The above story is based on materials provided by American Chemical Society. Note: Materials may be edited for content and length.


Cite This Page:

American Chemical Society. "Study Calls For Action On Heart Risks From Certain Anti-cancer Drugs." ScienceDaily. ScienceDaily, 28 April 2008. <www.sciencedaily.com/releases/2008/04/080428091709.htm>.
American Chemical Society. (2008, April 28). Study Calls For Action On Heart Risks From Certain Anti-cancer Drugs. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2008/04/080428091709.htm
American Chemical Society. "Study Calls For Action On Heart Risks From Certain Anti-cancer Drugs." ScienceDaily. www.sciencedaily.com/releases/2008/04/080428091709.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Fauci: Ebola Protocols to Focus on Training

Fauci: Ebola Protocols to Focus on Training

AP (Oct. 20, 2014) Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, says he expects revised CDC protocols on Ebola to focus on training, observation and ensuring health care workers are more protected. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins